IBRI IN THE NEWS: BioCrossroads Adds to Board
June 07, 2021
BioCrossroads has added Adrienne Brown and Alan Palkowitz to its board of directors. Brown serves as vice president of US Diabetes at Eli Lilly and Co. and oversees commercial efforts for Lilly USA's largest business unit and previously served as business unit director of Lilly Japan. Palkowitz serves as president and chief executive officer of the Indiana Biosciences Research Institute and previously served as vice president of discovery chemistry research and technologies at Eli Lilly and Co.
To read the full article, go to Inside INdiana Business.